Therapeutic area intelligence for Herbal Medicine with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 3
Catalysts: 0
Companies: 0

Companies

No related entities indexed yet.

Assets

Concerns →

Real-World →

Salvia →

Recent signals(3)

ClinicalJuly 24, 2026

Salvia miltiorrhiza shows promise in treating pulmonary fibrosis through fibroblast mitophagy

Salvia miltiorrhiza Bunge has demonstrated potential anti-fibrotic effects in pulmonary fibrosis through promoting fibroblast mitophagy.

RegulatoryJuly 24, 2026

Concerns Raised Over Hepatotoxicity of Epimedium brevicornu Maxim.

Epimedium brevicornu Maxim., traditionally considered non-toxic, is associated with increasing hepatobiliary toxicity.

CompetitiveJuly 5, 2026

Real-World Study on Dong'e Brand Ejiao Yuanjiang for Sleep Improvement

A real-world study is evaluating the sleep-improving efficacy of Dong'e Brand Ejiao Yuanjiang with 66 participants over 60 days.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

Pulmonary Fibrosis →

Sleep Disorders →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.